Cargando…

Reversible Silencing of CFTR Chloride Channels by Glutathionylation

The cystic fibrosis transmembrane conductance regulator (CFTR) is a phosphorylation- and ATP-dependent chloride channel that modulates salt and water transport across lung and gut epithelia. The relationship between CFTR and oxidized forms of glutathione is of potential interest because reactive glu...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Wei, Oliva, Claudia, Li, Ge, Holmgren, Arne, Lillig, Christopher Horst, Kirk, Kevin L.
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2217496/
https://www.ncbi.nlm.nih.gov/pubmed/15657297
http://dx.doi.org/10.1085/jgp.200409115
_version_ 1782149266360238080
author Wang, Wei
Oliva, Claudia
Li, Ge
Holmgren, Arne
Lillig, Christopher Horst
Kirk, Kevin L.
author_facet Wang, Wei
Oliva, Claudia
Li, Ge
Holmgren, Arne
Lillig, Christopher Horst
Kirk, Kevin L.
author_sort Wang, Wei
collection PubMed
description The cystic fibrosis transmembrane conductance regulator (CFTR) is a phosphorylation- and ATP-dependent chloride channel that modulates salt and water transport across lung and gut epithelia. The relationship between CFTR and oxidized forms of glutathione is of potential interest because reactive glutathione species are produced in inflamed epithelia where they may be modulators or substrates of CFTR. Here we show that CFTR channel activity in excised membrane patches is markedly inhibited by several oxidized forms of glutathione (i.e., GSSG, GSNO, and glutathione treated with diamide, a strong thiol oxidizer). Three lines of evidence indicate that the likely mechanism for this inhibitory effect is glutathionylation of a CFTR cysteine (i.e., formation of a mixed disulfide with glutathione): (a) channels could be protected from inhibition by pretreating the patch with NEM (a thiol alkylating agent) or by lowering the bath pH; (b) inhibited channels could be rescued by reducing agents (e.g., DTT) or by purified glutaredoxins (Grxs; thiol disulfide oxidoreductases) including a mutant Grx that specifically reduces mixed disulfides between glutathione and cysteines within proteins; and (c) reversible glutathionylation of CFTR polypeptides in microsomes could be detected biochemically under the same conditions. At the single channel level, the primary effect of reactive glutathione species was to markedly inhibit the opening rates of individual CFTR channels. CFTR channel inhibition was not obviously dependent on phosphorylation state but was markedly slowed when channels were first “locked open” by a poorly hydrolyzable ATP analogue (AMP-PNP). Consistent with the latter finding, we show that the major site of inhibition is cys-1344, a poorly conserved cysteine that lies proximal to the signature sequence in the second nucleotide binding domain (NBD2) of human CFTR. This region is predicted to participate in ATP-dependent channel opening and to be occluded in the nucleotide-bound state of the channel based on structural comparisons to related ATP binding cassette transporters. Our results demonstrate that human CFTR channels are reversibly inhibited by reactive glutathione species, and support an important role of the region proximal to the NBD2 signature sequence in ATP-dependent channel opening.
format Text
id pubmed-2217496
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-22174962008-03-21 Reversible Silencing of CFTR Chloride Channels by Glutathionylation Wang, Wei Oliva, Claudia Li, Ge Holmgren, Arne Lillig, Christopher Horst Kirk, Kevin L. J Gen Physiol Article The cystic fibrosis transmembrane conductance regulator (CFTR) is a phosphorylation- and ATP-dependent chloride channel that modulates salt and water transport across lung and gut epithelia. The relationship between CFTR and oxidized forms of glutathione is of potential interest because reactive glutathione species are produced in inflamed epithelia where they may be modulators or substrates of CFTR. Here we show that CFTR channel activity in excised membrane patches is markedly inhibited by several oxidized forms of glutathione (i.e., GSSG, GSNO, and glutathione treated with diamide, a strong thiol oxidizer). Three lines of evidence indicate that the likely mechanism for this inhibitory effect is glutathionylation of a CFTR cysteine (i.e., formation of a mixed disulfide with glutathione): (a) channels could be protected from inhibition by pretreating the patch with NEM (a thiol alkylating agent) or by lowering the bath pH; (b) inhibited channels could be rescued by reducing agents (e.g., DTT) or by purified glutaredoxins (Grxs; thiol disulfide oxidoreductases) including a mutant Grx that specifically reduces mixed disulfides between glutathione and cysteines within proteins; and (c) reversible glutathionylation of CFTR polypeptides in microsomes could be detected biochemically under the same conditions. At the single channel level, the primary effect of reactive glutathione species was to markedly inhibit the opening rates of individual CFTR channels. CFTR channel inhibition was not obviously dependent on phosphorylation state but was markedly slowed when channels were first “locked open” by a poorly hydrolyzable ATP analogue (AMP-PNP). Consistent with the latter finding, we show that the major site of inhibition is cys-1344, a poorly conserved cysteine that lies proximal to the signature sequence in the second nucleotide binding domain (NBD2) of human CFTR. This region is predicted to participate in ATP-dependent channel opening and to be occluded in the nucleotide-bound state of the channel based on structural comparisons to related ATP binding cassette transporters. Our results demonstrate that human CFTR channels are reversibly inhibited by reactive glutathione species, and support an important role of the region proximal to the NBD2 signature sequence in ATP-dependent channel opening. The Rockefeller University Press 2005-02 /pmc/articles/PMC2217496/ /pubmed/15657297 http://dx.doi.org/10.1085/jgp.200409115 Text en Copyright © 2005, The Rockefeller University Press This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Article
Wang, Wei
Oliva, Claudia
Li, Ge
Holmgren, Arne
Lillig, Christopher Horst
Kirk, Kevin L.
Reversible Silencing of CFTR Chloride Channels by Glutathionylation
title Reversible Silencing of CFTR Chloride Channels by Glutathionylation
title_full Reversible Silencing of CFTR Chloride Channels by Glutathionylation
title_fullStr Reversible Silencing of CFTR Chloride Channels by Glutathionylation
title_full_unstemmed Reversible Silencing of CFTR Chloride Channels by Glutathionylation
title_short Reversible Silencing of CFTR Chloride Channels by Glutathionylation
title_sort reversible silencing of cftr chloride channels by glutathionylation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2217496/
https://www.ncbi.nlm.nih.gov/pubmed/15657297
http://dx.doi.org/10.1085/jgp.200409115
work_keys_str_mv AT wangwei reversiblesilencingofcftrchloridechannelsbyglutathionylation
AT olivaclaudia reversiblesilencingofcftrchloridechannelsbyglutathionylation
AT lige reversiblesilencingofcftrchloridechannelsbyglutathionylation
AT holmgrenarne reversiblesilencingofcftrchloridechannelsbyglutathionylation
AT lilligchristopherhorst reversiblesilencingofcftrchloridechannelsbyglutathionylation
AT kirkkevinl reversiblesilencingofcftrchloridechannelsbyglutathionylation